Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

825 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J. Antoni CE, et al. Among authors: burmester gr. Arthritis Rheum. 2005 Apr;52(4):1227-36. doi: 10.1002/art.20967. Arthritis Rheum. 2005. PMID: 15818699 Free article. Clinical Trial.
p205 is a major target of autoreactive T cells in rheumatoid arthritis.
Bläss S, Schumann F, Hain NA, Engel JM, Stuhlmüller B, Burmester GR. Bläss S, et al. Among authors: burmester gr. Arthritis Rheum. 1999 May;42(5):971-80. doi: 10.1002/1529-0131(199905)42:5<971::AID-ANR16>3.0.CO;2-A. Arthritis Rheum. 1999. PMID: 10323453 Free article.
Anti-CD4 therapy in rheumatoid arthritis.
Burmester GR, Emmrich F. Burmester GR, et al. Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S139-45. Clin Exp Rheumatol. 1993. PMID: 8100750 Review.
825 results